Post-marketing safety surveillance of the novel muscarinic antipsychotic Xanomeline-Trospium for schizophrenia: A comparative disproportionality analysis against olanzapine based on FAERS data

Psychiatry Research 2026

View at publisher

Authors: Yulan Zeng, Xueting Wang, Hao Wu, Xiyue Tan, Ruixia Wang, Yuxia Liu, Junguo Duan

DOI: 10.1016/j.psychres.2026.117270

Cited by: 1

References: 37

Fields of Study & Subjects

Pharmacovigilance and Adverse Drug Reactions Schizophrenia research and treatment Advanced Causal Inference Techniques

References 37